Third-generation oral contraceptives and venous thrombosis
- 1 March 1997
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 349 (9053) , 731-732
- https://doi.org/10.1016/s0140-6736(05)60173-0
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Population-based study of risk of venous thromboembolism associated with various oral contraceptivesThe Lancet, 1997
- Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic diseaseThe Lancet, 1995
- Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen componentsThe Lancet, 1995
- Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagenThe Lancet, 1995